At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 May 2001 No-Development-Reported for Cancer in South Korea (Unknown route)
- 13 Nov 1998 New profile
- 13 Nov 1998 Preclinical development for Cancer in South Korea (Unknown route)